What is SI-BONE?
Founded in April 2008 and headquartered in Santa Clara, California, SI-BONE is dedicated to advancing treatments for sacroiliac joint issues. The company's proprietary iFuse Technology is central to its product development, aiming to provide effective surgical interventions. This focus places SI-BONE at the intersection of medical device innovation and orthopedic surgery, a sector characterized by rigorous clinical validation and a demand for improved patient outcomes. The company's commitment to addressing complex spinal conditions positions it as a key player in the evolving landscape of spine care.
How much funding has SI-BONE raised?
SI-BONE has raised a total of $399.4M across 10 funding rounds:
Unspecified
$16M
Private Equity
$33M
Private Equity
$21M
Debt
$39.2M
Private Equity
$20M
Stock Offering
$124.2M
Stock Offering
$53.5M
Debt
$40M
Debt
$51M
Unspecified (2011): $16M led by Skyline Ventures and Montreux Equity Partners
Private Equity (2014): $33M supported by Skyline Ventures, Montreux Equity Partners, OrbiMed, and Novo A/S
Private Equity (2015): $21M featuring OrbiMed, Redline Capital Management, Skyline Ventures, and Montreux Equity Partners
Debt (2015): $39.2M backed by Oxford Finance and Silicon Valley Bank
Private Equity (2016): $20M with participation from OrbiMed, Skyline Ventures, Montreux Equity Partners, Arboretum Ventures, Novo A/S, and Redline Capital Management
Stock Issuance/Offering (2018): $124.2M, investors not publicly disclosed
Stock Issuance/Offering (2020): $53.5M, investors not publicly disclosed
Debt (2020): $40M featuring Solar Capital Partners
Debt (2023): $51M backed by Silicon Valley Bank
Key Investors in SI-BONE
OrbiMed
OrbiMed Advisors LLC is a specialized investment firm with deep expertise in the healthcare sector, managing capital across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. They actively engage with portfolio companies on strategic initiatives and operational optimization.
Skyline Ventures
Skyline Ventures is a venture capital firm specializing in product-focused healthcare companies, with expertise in medical devices, therapeutics, and diagnostics. They are known for providing significant value to their portfolio companies.
Montreux Equity Partners
Montreux Growth Partners focuses on investing in high-growth, commercial-stage companies offering leading products and technologies. They specialize in accelerating the scale of their investments to drive growth in innovative companies.
What's next for SI-BONE?
The recent major strategic investment signals a new phase of expansion for SI-BONE. This capital infusion is likely to fuel further research and development into its iFuse Technology, potentially leading to new product lines or enhancements for existing offerings. Furthermore, the funding may support an acceleration of market penetration, both domestically and internationally, through expanded sales and marketing initiatives. Strategic partnerships or acquisitions could also be on the horizon as the company seeks to solidify its leadership in the sacropelvic solutions market. The company's trajectory suggests a continued focus on innovation and market leadership within the specialized field of spinal implants.
See full SI-BONE company page
